Market Overview:
The global colon targeted drug delivery systems market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in the field of drug delivery systems. Based on type, the global colon targeted drug delivery systems market is segmented into pressure controlled drug-delivery systems and osmotic controlled drug-delivery (ORDS-CT). The pressure controlled drug-delivery system segment is expected to dominate the global market during the forecast period owing to its advantages such as precise dosing and reduced side effects as compared to other types of colon targeted drug delivery systems. Based on application, the hospital segment dominates this market followed by biology laboratories and other segments.
Product Definition:
A Colon Targeted Drug Delivery System is a drug delivery system that delivers drugs to the colon. The importance of Colon Targeted Drug Delivery Systems is that it can improve the absorption of drugs into the body, which can improve the effectiveness of treatments.
Pressure Controlled Drug-Delivery Systems:
The global pressure controlled drug-delivery systems market was valued at USD 6.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases has led to an increase in demand for targeted drug delivery systems which are known to be more effective than conventional methods owing to their ability of delivering precise doses at specific locations with reduced toxicity levels.
Osmotic Controlled Drug Delivery (ORDS-CT):
Osmotic controlled drug delivery systems are also known as osmotic colonic drug delivery system. It is a method of delivering drugs to the colon via the small intestine by using osmotic agents such as sodium phosphate or mannitol. The mechanism of action involves disruption of cellular membranes leading to cell death and/or membrane permeability, thus allowing the entry of drugs into the cells.
Application Insights:
Based on application, the global colon targeted drug delivery systems market is segmented into hospital, biology laboratory and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as increasing prevalence of chronic diseases and growing geriatric population across the globe. Moreover, an increase in number of surgeries being performed has also positively influenced demand for these products globally over the past few years.
The other application segment includes clinics/hospitals and home care settings that use these products for treating patients with constipation or diarrhea caused due to IBS (irritable bowel syndrome) or CCD (colitis chronic disease), respectively.
Regional Analysis:
North America colon targeted drug delivery systems market accounted for the largest share of over 40.0% in 2017 owing to the technological advancements and high adoption rate of advanced medical products in this region. The introduction of new technologies such as wireless remote patient monitoring, real-time interactive video & audio communication between physicians and patients is expected to drive the demand for colon targeted drug delivery systems during the forecast period.
Asia Pacific is estimated to be one of lucrative regions with a CAGR exceeding 6.0% from 2018 to 2030 due its huge population base suffering from various diseases such as diabetes, obesity, & cancer which require long term treatment with drugs that need continuous infusion through vein or artery routes; hence driving up demand for ORDS system applications in Asia Pacific region over next eight years.
Growth Factors:
- Increasing incidence of colorectal cancer: The incidence of colorectal cancer is increasing at an alarming rate across the globe. This is primarily attributed to the changing lifestyle and dietary habits of people. This, in turn, is expected to boost the demand for colon targeted drug delivery systems over the forecast period.
- Growing awareness about early diagnosis and treatment: There is a growing awareness among people about the importance of early diagnosis and treatment for colorectal cancer. This is likely to fuel demand for colon targeted drug delivery systems in the coming years.
- Technological advancements: The technological advancements in drug delivery systems are providing new opportunities for manufacturers operating in this market space. These advancements are helping them develop more advanced and efficient products that can target specific areas within the body, such as the colon, with greater precision. This is expected to drive growth of this market during the forecast period..
Scope Of The Report
Report Attributes
Report Details
Report Title
Colon Targeted Drug Delivery Systems Market Research Report
By Type
Pressure Controlled Drug-Delivery Systems, Osmotic Controlled Drug Delivery (ORDS-CT), Others
By Application
Hospital, Biology Laboratory, Other
By Companies
Evonik, Tillotts Pharma (Zeria Group), Lonza Pharma Biotech, Bayer AG, Johnson and Johnson (Janssen)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Colon Targeted Drug Delivery Systems Market Report Segments:
The global Colon Targeted Drug Delivery Systems market is segmented on the basis of:
Types
Pressure Controlled Drug-Delivery Systems, Osmotic Controlled Drug Delivery (ORDS-CT), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Biology Laboratory, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Evonik
- Tillotts Pharma (Zeria Group)
- Lonza Pharma Biotech
- Bayer AG
- Johnson and Johnson (Janssen)
Highlights of The Colon Targeted Drug Delivery Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pressure Controlled Drug-Delivery Systems
- Osmotic Controlled Drug Delivery (ORDS-CT)
- Others
- By Application:
- Hospital
- Biology Laboratory
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Colon Targeted Drug Delivery Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Colon targeted drug delivery systems are a type of medical device that are designed to deliver medications directly to the colon. These devices can be used to treat conditions such as Crohn's disease, ulcerative colitis, and cancer.
Some of the key players operating in the colon targeted drug delivery systems market are Evonik, Tillotts Pharma (Zeria Group), Lonza Pharma Biotech, Bayer AG, Johnson and Johnson (Janssen).
The colon targeted drug delivery systems market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Colon Targeted Drug Delivery Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Colon Targeted Drug Delivery Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Colon Targeted Drug Delivery Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Colon Targeted Drug Delivery Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Colon Targeted Drug Delivery Systems Market Size & Forecast, 2018-2028
4.5.1 Colon Targeted Drug Delivery Systems Market Size and Y-o-Y Growth
4.5.2 Colon Targeted Drug Delivery Systems Market Absolute $ Opportunity
Chapter 5 Global Colon Targeted Drug Delivery Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Colon Targeted Drug Delivery Systems Market Size Forecast by Type
5.2.1 Pressure Controlled Drug-Delivery Systems
5.2.2 Osmotic Controlled Drug Delivery (ORDS-CT)
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Colon Targeted Drug Delivery Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Colon Targeted Drug Delivery Systems Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Biology Laboratory
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Colon Targeted Drug Delivery Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Colon Targeted Drug Delivery Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Colon Targeted Drug Delivery Systems Analysis and Forecast
9.1 Introduction
9.2 North America Colon Targeted Drug Delivery Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Colon Targeted Drug Delivery Systems Market Size Forecast by Type
9.6.1 Pressure Controlled Drug-Delivery Systems
9.6.2 Osmotic Controlled Drug Delivery (ORDS-CT)
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Colon Targeted Drug Delivery Systems Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Biology Laboratory
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Colon Targeted Drug Delivery Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Colon Targeted Drug Delivery Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Colon Targeted Drug Delivery Systems Market Size Forecast by Type
10.6.1 Pressure Controlled Drug-Delivery Systems
10.6.2 Osmotic Controlled Drug Delivery (ORDS-CT)
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Colon Targeted Drug Delivery Systems Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Biology Laboratory
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Colon Targeted Drug Delivery Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Colon Targeted Drug Delivery Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Colon Targeted Drug Delivery Systems Market Size Forecast by Type
11.6.1 Pressure Controlled Drug-Delivery Systems
11.6.2 Osmotic Controlled Drug Delivery (ORDS-CT)
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Colon Targeted Drug Delivery Systems Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Biology Laboratory
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Colon Targeted Drug Delivery Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Colon Targeted Drug Delivery Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Colon Targeted Drug Delivery Systems Market Size Forecast by Type
12.6.1 Pressure Controlled Drug-Delivery Systems
12.6.2 Osmotic Controlled Drug Delivery (ORDS-CT)
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Colon Targeted Drug Delivery Systems Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Biology Laboratory
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Colon Targeted Drug Delivery Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Colon Targeted Drug Delivery Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Colon Targeted Drug Delivery Systems Market Size Forecast by Type
13.6.1 Pressure Controlled Drug-Delivery Systems
13.6.2 Osmotic Controlled Drug Delivery (ORDS-CT)
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Colon Targeted Drug Delivery Systems Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Biology Laboratory
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Colon Targeted Drug Delivery Systems Market: Competitive Dashboard
14.2 Global Colon Targeted Drug Delivery Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Evonik
14.3.2 Tillotts Pharma (Zeria Group)
14.3.3 Lonza Pharma Biotech
14.3.4 Bayer AG
14.3.5 Johnson and Johnson (Janssen)
